Bergenia ligulata (Wall.) Engl.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | B. ciliata Sternb. Saxifraga ligulata Wall. |
| Family | Saxifragaceae. |
| Habitat | Temperate Himalaya from Kashmir to Bhutan, between altitudes of 900 and 3,000 m. |
| Ayurvedic | Paashaanabheda, Ashmaribhedikaa, Ashmaribhit, Ashmghna, Shilaabhit, Shilaabheda. (These synonyms are also equated with Aerva lanata Juss.) |
| Siddha / Tamil | Padanbethi. |
| Action | Leaf and root—antiscorbutic, astringent, spasmolytic, antidiarrhoeal. Used in dysuria, spleen enlargement, pulmonary affections as a cough remedy, menorrhagia, urinary tract infections. Alcoholic extract of roots— antilithic. Acetone extract of rootbark—cardiotoxic, CNS depressant and anti-inflammatory; in mild doses diuretic but antidiuretic in higher doses. Anti-inflammatory activity decreases with increasing dosage. Due to its depressant action on the central nervous system, the drug is used against vertigo, dizziness and headache in moderate or low dosage. |
| Key Application | In lithiasis, dysuria, polyuria. (The Ayurvedic Pharmacopoeia of India; Indian Herbal Pharmacopoeia.) |
| Dosage | Rhizome—20–30 g for decoction. (API Vol. I) |
| Taxonomic Cohort | Genus Bergenia (1 documented species); Family Saxifragaceae (2 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Bergenia ligulata (taxonomically cited with authority (Wall.) Engl.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Saxifragaceae (primary family classification: Saxifragaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. ciliata Sternb. Saxifraga ligulata Wall, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Temperate Himalaya from Kashmir to Bhutan, between altitudes of 900 and 3,000 m.
Across classical and vernacular Indian systems of medicine, Bergenia ligulata is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Paashaanabheda, Ashmaribhedikaa, Ashmaribhit, Ashmghna, Shilaabhit, Shilaabheda. (These synonyms are also equated with Aerva lanata Juss.); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Padanbethi. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bergenia ligulata are: Leaf and root—antiscorbutic, astringent, spasmolytic, antidiarrhoeal. Used in dysuria, spleen enlargement, pulmonary affections as a cough remedy, menorrhagia, urinary tract infections. Alcoholic extract of roots— antilithic. Acetone extract of rootbark—cardiotoxic, CNS depressant and anti-inflammatory; in mild doses diuretic but antidiuretic in higher doses. Anti-inflammatory activity decreases with increasing dosage. Due to its depressant action on the central nervous system, the drug is used against vertigo, dizziness and headache in moderate or low dosage. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: In lithiasis, dysuria, polyuria. (The Ayurvedic Pharmacopoeia of India; Indian Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bergenia ligulata establish the following evidence base: The rhizome contains an active principle bergenin (0.6%), gallic acid, glucose (5.6%), tannins (14.2–016.3%), mucilage and wax; a C-glycoside and beta-sitosterol. Bergenin prevented stress-induced erosions in rats and lowered gastric outputs. (Paashaanabheda indicates that the plant grows between rocks appearing to break them; it does not necessarily mean that it possesses lithotriptic property.)
In specialized pharmacognostic classifications, Bergenia ligulata is also recognized among important classical herbs with divergent regional plant sources across North and South Indian formularies; and listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Bergenia ligulata rhizome.

Figure 2: Authenticated crude herb specimen — Saxifraga ligulata rhizome.

Botanical Reference 1: Bergenia ligulata — Botanical specimen

Botanical Reference 2: Bergenia ligulata — Botanical specimen

Botanical Reference 3: Bergenia ligulata — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Bergenia ligulata stands as a distinct representative of the genus Bergenia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Saxifragaceae encompasses 2 documented medicinal species (0.11% of the 1,814-species flora). Other representative medicinal members of Saxifragaceae include: Dichroa febrifuga (Basak). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 3: Quantitative documentation profile across all 2 medicinal species of family Saxifragaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Bergenia ligulata are prescribed as follows: Rhizome—20–30 g for decoction. (API Vol. I). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Bergenia ligulata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.